HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monica M Reinholz Selected Research

Indicators and Reagents (Reagents)

8/2013Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monica M Reinholz Research Topics

Disease

16Breast Neoplasms (Breast Cancer)
08/2017 - 06/2002
15Neoplasms (Cancer)
08/2017 - 06/2002
3Neoplasm Metastasis (Metastasis)
07/2010 - 06/2002
1Circulating Neoplastic Cells
11/2011
1Leukemia
12/2010
1Osteosarcoma (Osteogenic Sarcoma)
12/2010
1Bone Diseases (Bone Disease)
07/2010
1Multiple Myeloma
07/2010
1Endometrial Neoplasms (Endometrial Cancer)
02/2005
1Noninfiltrating Intraductal Carcinoma (DCIS)
06/2002

Drug/Important Bio-Agent (IBA)

7Trastuzumab (Herceptin)FDA Link
08/2017 - 10/2010
5Proteins (Proteins, Gene)FDA Link
08/2017 - 06/2002
4ErbB Receptors (EGF Receptor)IBA
03/2015 - 04/2008
4human ERBB2 proteinIBA
08/2013 - 12/2010
3Estrogen ReceptorsIBA
08/2017 - 12/2010
3Messenger RNA (mRNA)IBA
03/2015 - 06/2002
3Transforming Growth Factor beta (TGF-beta)IBA
02/2005 - 06/2002
2Hormones (Hormone)IBA
10/2013 - 10/2010
2Formaldehyde (Formol)FDA Link
01/2013 - 12/2010
2ParaffinIBA
01/2013 - 12/2010
2RNA (Ribonucleic Acid)IBA
12/2010 - 02/2005
1Progesterone Receptors (Progesterone Receptor)IBA
08/2017
1Epidermal Growth Factor (EGF)IBA
02/2014
1Indicators and Reagents (Reagents)IBA
08/2013
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
06/2013
1Complementary DNA (cDNA)IBA
01/2013
1Keratin-19 (Keratin 19)IBA
11/2011
1Type II DNA Topoisomerases (Topoisomerase II)IBA
12/2010
1SurvivinIBA
12/2010
1Wnt-5a ProteinIBA
12/2010
1GRB7 Adaptor ProteinIBA
12/2010
1Cyclin A2IBA
12/2010
1Phosphates (Orthophosphate)IBA
07/2010
1AntimetabolitesIBA
07/2010
1AnhydridesIBA
07/2010
1Zoledronic Acid (Zometa)FDA Link
07/2010
1Etidronic Acid (HEDP)FDA LinkGeneric
07/2010
1Diphosphonates (Bisphosphonates)IBA
07/2010
1Dihydrotachysterol (AT 10)IBA
07/2010
1NucleosidesIBA
07/2010
1Tyrosine Kinase InhibitorsIBA
04/2008
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
04/2008
1Actins (F Actin)IBA
05/2005
1Tumor Biomarkers (Tumor Markers)IBA
05/2005
1Inhibins (Inhibin)IBA
06/2002
1inhibin-alpha subunitIBA
06/2002
1inhibin beta A subunitIBA
06/2002
1OsteoprotegerinIBA
06/2002
1OsteopontinIBA
06/2002
1LigandsIBA
06/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2002
1CytokinesIBA
06/2002
1Bone Morphogenetic Protein 2IBA
06/2002
1NF-kappa B (NF-kB)IBA
06/2002

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2013 - 10/2010
3Therapeutics
02/2014 - 04/2008
1Combination Drug Therapy (Combination Chemotherapy)
03/2015
1Ligation
01/2013
1Palliative Care (Palliative Therapy)
07/2010